Streetbeat News

Analyst Ratings

MRVL

Susquehanna analyst Christopher Rolland maintains a Positive rating on Marvell Tech (NASDAQ:MRVL) and raises the price target from $80 to $95.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 1:01 pm

TXT

B of A Securities analyst Ronald Epstein upgraded Textron (NYSE:TXT) from Neutral to Buy and increased the price target from $85 to $105.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 1:01 pm

AVGO

Susquehanna analyst Christopher Rolland maintains a Positive rating on Broadcom (NASDAQ:AVGO) and raises the price target from $1550 to $1650.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 1:01 pm

AMLX

Four analysts have recently shared their views on Amylyx Pharma (NASDAQ:AMLX), with ratings ranging from bullish to somewhat bullish. The average 12-month price target is now $33.00, down from $36.50, indicating a 9.59% decrease. Amylyx Pharma has shown significant revenue growth of 395.54% as of December 31, 2023, and outperforms in net margin, ROE, and ROA, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 1:00 pm

ASB

Analyst ratings for Associated Banc (NYSE:ASB) have shown a mix of opinions, with recent updates indicating a positive shift in sentiment. The average 12-month price target has been raised to $23.25, reflecting an 8.14% increase from the previous target. Analysts from Barclays, Raymond James, Piper Sandler, and RBC Capital have adjusted their ratings and price targets, suggesting a cautiously optimistic outlook. Despite this, Associated Banc faces financial challenges, including a significant revenue decline and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 1:00 pm

IOT

Piper Sandler analyst James Fish maintains a Neutral rating on Samsara (NYSE:IOT) and raises the price target from $33 to $41.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:59 pm

RGNX

RBC Capital analyst Luca Issi upgraded Regenxbio (NASDAQ:RGNX) from Sector Perform to Outperform and increased the price target from $20 to $35.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:59 pm

AVGO

Piper Sandler analyst Harsh Kumar has maintained an Overweight rating on Broadcom (NASDAQ:AVGO) and increased the price target from $1250 to $1650.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:58 pm

GPS

Gap Inc. (NYSE:GPS) reported Q4 earnings that surpassed expectations with a revenue increase of 1% year-over-year to $4.30 billion and earnings of 49 cents per share, beating estimates. The company expects flat net sales for Q1 and full-year 2024 but anticipates margin expansion. Following the report, several analysts raised their price targets on Gap shares, which gained 1.4% to close at $19.33.

Portfolio Pulse from Avi Kapoor

March 08, 2024 | 12:57 pm

AVGO

TD Cowen analyst Matthew Ramsay maintains a Market Perform rating on Broadcom (NASDAQ:AVGO) and raises the price target from $1000 to $1400.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:57 pm